In humans, side effects possibly caused by the PD-1/PD-L1 inhibiting–mAbs include infusion-related reactions, hypersensitivity, pneumonitis, colitis, diarrhoea and hypothyroidism5, 12, 22. Here, PDCD1 is linked to pneumonitis.